# Avidity Partners Management LP 13F Q2 2026: $624 million

Avidity Partners Management LP reported $624 million in 13F securities across 45 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Dianthus Therapeutics Inc at $205 million, 32.8% of the reported value. Since Q1 2026 it opened 9 new positions and exited 16.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $624,441,478
- Positions: 45
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1791827
- Form 13F file number: 028-20028
- Business address: 2828 N Harwood Street Suite 1220, Dallas, TX 75201
- SEC filing: [0001791827-26-000005](https://www.sec.gov/Archives/edgar/data/1791827/000179182726000005/0001791827-26-000005-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/avidity-partners-management-lp-304628)

## Top 25 holdings by value

The largest of 45 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 2,104,184 | $205.1 million | -2,104,184 |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 1,398,948 | $99.4 million | +110,000 |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 760,424 | $72.4 million | -760,424 |
| [Jade Biosciences Inc](https://specstream.ai/data/institutional-holders/jade-biosciences-inc-008064206) | COM NEW | 1,700,708 | $37.8 million | -1,100,708 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 550,000 | $27.9 million | -250,000 |
| [Perspective Therapeutics Inc](https://specstream.ai/data/institutional-holders/perspective-therapeutics-inc-46489v302) | COM NEW | 6,299,999 | $21.5 million | -5,799,999 |
| [Aktis Oncology Inc](https://specstream.ai/data/institutional-holders/aktis-oncology-inc-01021m104) | COM | 484,200 | $15.6 million | -452,932 |
| [Palvella Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/palvella-therapeutics-inc-ne-697947109) | COM | 70,000 | $10.7 million | -70,000 |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 798,282 | $10.7 million | New |
| [Repligen Corp](https://specstream.ai/data/institutional-holders/repligen-corp-759916109) | COM | 77,800 | $10.6 million | -77,800 |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 669,941 | $10.3 million | New |
| [Senseonics Hldgs Inc](https://specstream.ai/data/institutional-holders/senseonics-hldgs-inc-81727u303) | COM | 1,600,000 | $9.1 million | New |
| [Karyopharm Therapeutics Inc](https://specstream.ai/data/institutional-holders/karyopharm-therapeutics-inc-48576u205) | COM NEW | 924,487 | $9 million | -2,995 |
| [Teva Pharmaceutical Inds LTD](https://specstream.ai/data/institutional-holders/teva-pharmaceutical-inds-ltd-881624209) | SPONSORED ADS | 200,000 | $6.8 million | -450,100 |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 100,000 | $6.7 million | -90,000 |
| [Tempus AI Inc](https://specstream.ai/data/institutional-holders/tempus-ai-inc-88023b103) | CL A | 105,000 | $6.1 million | +15,000 |
| [Medtronic PLC](https://specstream.ai/data/institutional-holders/medtronic-plc-g5960l103) | SHS | 70,000 | $5.5 million | -130,000 |
| [Vir Biotechnology Inc](https://specstream.ai/data/institutional-holders/vir-biotechnology-inc-92764n102) | COM | 519,300 | $5.3 million | -1,050,000 |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 98,000 | $5.3 million | +20,000 |
| [Encompass Health Corp](https://specstream.ai/data/institutional-holders/encompass-health-corp-29261a100) | COM | 42,000 | $4.2 million | -42,000 |
| [Tenax Therapeutics Inc](https://specstream.ai/data/institutional-holders/tenax-therapeutics-inc-88032l605) | COM NEW | 265,934 | $3.9 million | -215,934 |
| [Nuvectis Pharma Inc](https://specstream.ai/data/institutional-holders/nuvectis-pharma-inc-67080t108) | COM | 200,000 | $3.7 million | New |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 24,000 | $3.7 million | +14,000 |
| [Boston Scientific Corp](https://specstream.ai/data/institutional-holders/boston-scientific-corp-101137107) | COM | 80,000 | $3.4 million | -40,000 |
| [Satellos Bioscience Inc](https://specstream.ai/data/institutional-holders/satellos-bioscience-inc-80401l803) | COM | 387,769 | $3 million | -387,769 |

## New positions in Q2 2026

9 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 798,282 | $10.7 million |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 669,941 | $10.3 million |
| [Senseonics Hldgs Inc](https://specstream.ai/data/institutional-holders/senseonics-hldgs-inc-81727u303) | COM | 1,600,000 | $9.1 million |
| [Nuvectis Pharma Inc](https://specstream.ai/data/institutional-holders/nuvectis-pharma-inc-67080t108) | COM | 200,000 | $3.7 million |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 110,000 | $3 million |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 60,000 | $2 million |
| [Kailera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kailera-therapeutics-inc-482931102) | COMMON STOCK | 80,000 | $1.8 million |
| [Scynexis Inc](https://specstream.ai/data/institutional-holders/scynexis-inc-811292309) | COM | 260,206 | $1.1 million |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 75,000 | $996,750 |

## Positions exited in Q2 2026

16 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Immunic Inc | COM | 7,369,352 | $13.9 million |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 25,000 | $5.9 million |
| Scynexis Inc | COM NEW | 4,163,320 | $3.8 million |
| [Icon PLC](https://specstream.ai/data/institutional-holders/icon-plc-g4705a100) | SHS | 32,000 | $3.7 million |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 18,000 | $3.7 million |
| [Hims & Hers Health Inc](https://specstream.ai/data/institutional-holders/hims-hers-health-inc-433000106) | COM CL A | 125,000 | $2.9 million |
| [Corcept Therapeutics Inc](https://specstream.ai/data/institutional-holders/corcept-therapeutics-inc-218352102) | COM | 60,000 | $2.6 million |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 70,000 | $2.3 million |
| [Anteris Technologies Global](https://specstream.ai/data/institutional-holders/anteris-technologies-global-03675p102) | COM | 300,000 | $1.8 million |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 100,000 | $1.8 million |
| [Kenvue Inc](https://specstream.ai/data/institutional-holders/kenvue-inc-49177j102) | COM | 100,000 | $1.7 million |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 15,000 | $1.5 million |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 10,000 | $1.1 million |
| [Arbutus Biopharma Corp](https://specstream.ai/data/institutional-holders/arbutus-biopharma-corp-03879j100) | COM | 250,000 | $1.1 million |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 3,800 | $1 million |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 25,934 | $579,754 |

## Also on SpecStream

- [Avidity Partners Management LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1791827/000179182726000005/0001791827-26-000005-index.htm)
- [Avidity Partners Management LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/avidity-partners-management-lp-304628)
- [Largest 13F filers in Texas](https://specstream.ai/data/institutional-holdings/state/texas)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Dallas, Texas

- [Garage door companies in Dallas, Texas](https://specstream.ai/data/businesses/garage-door-companies/dallas-texas-united-states)
- [Life insurance agencies in Dallas, Texas](https://specstream.ai/data/businesses/life-insurance-agencies/dallas-texas-united-states)
- [Physical therapy clinics in Dallas, Texas](https://specstream.ai/data/businesses/physical-therapy-clinics/dallas-texas-united-states)
- [Sports bars in Dallas, Texas](https://specstream.ai/data/businesses/sports-bars/dallas-texas-united-states)
- [Architectural design firms in Dallas, Texas](https://specstream.ai/data/businesses/architectural-design-firms/dallas-texas-united-states)
- [Cleaning companies in Dallas, Texas](https://specstream.ai/data/businesses/cleaning-companies/dallas-texas-united-states)
